» Articles » PMID: 37185530

Chemiluminescence Biosensor for the Determination of Cardiac Troponin I (cTnI)

Overview
Specialty Biotechnology
Date 2023 May 15
PMID 37185530
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiac vascular diseases, especially acute myocardial infarction (AMI), are one of the leading causes of death worldwide. Therefore cardio-specific biomarkers such as cardiac troponin I (cTnI) play an essential role in the field of diagnostics. In order to enable rapid and accurate measurement of cTnI with the potential of online measurements, a chemiluminescence-based immunosensor is presented as a proof of concept. A flow cell was designed and combined with a sensitive CMOS camera allowing sensitive optical readout. In addition, a microfluidic setup was established, which achieved selective and quasi-online cTnI determination within ten minutes. The sensor was tested with recombinant cTnI in phosphate buffer and demonstrated cTnI measurements in the concentration range of 2-25 µg/L. With the optimized system, a limit of detection (LoD) of 0.6 µg/L (23 pmol/L) was achieved. Furthermore, the selectivity of the immunosensor was investigated with other recombinant proteins, such as cTnT, and cTnC, at a level of 16 µg/L. No cross-reactivity could be observed. Measurements with diluted blood plasma and serum resulted in an LoD of 60 µg/L (2.4 nmol/L) and 70 µg/L (2.9 nmol/L), respectively.

Citing Articles

A Plasmonic Nanoledge Array Sensor for Selective Detection of Cardiovascular Disease Biomarkers in Human Whole Blood.

Tukur F, Mabe T, Liu M, Tukur P, Wei J ACS Appl Nano Mater. 2024; 7(17):20024-20033.

PMID: 39296866 PMC: 11406491. DOI: 10.1021/acsanm.4c02524.

References
1.
Salvador J, Vilaplana L, Marco M . Nanobody: outstanding features for diagnostic and therapeutic applications. Anal Bioanal Chem. 2019; 411(9):1703-1713. DOI: 10.1007/s00216-019-01633-4. View

2.
. Corrigendum to: 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12.... Eur Heart J. 2022; 43(42):4468. DOI: 10.1093/eurheartj/ehac458. View

3.
Taverna M, Marie A, Mira J, Guidet B . Specific antioxidant properties of human serum albumin. Ann Intensive Care. 2013; 3(1):4. PMC: 3577569. DOI: 10.1186/2110-5820-3-4. View

4.
Lohmann K, Westerdorf B, Maytum R, Geeves M, Jaquet K . Overexpression of human cardiac troponin in Escherichia coli: its purification and characterization. Protein Expr Purif. 2001; 21(1):49-59. DOI: 10.1006/prep.2000.1328. View

5.
Apple F, Sandoval Y, Jaffe A, Ordonez-Llanos J . Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care. Clin Chem. 2017; 63(1):73-81. DOI: 10.1373/clinchem.2016.255109. View